Alpha 2.0
Login Register
» Authors » Shubham Shukla

Shubham Shukla

Explore the profile of Shubham Shukla including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 49
Followers 0
Related Specialties
Nephrology
General Medicine
Biochemistry
Top 10 Co-Authors
Raja Ramachandran
Aravind Sekar
Sachin Naik
Manish Rathi
Ritambhra Nada
Jasmine Sethi
Vinod Kumar
Harbir Singh Kohli
Deeksha Pal
Ashwini Kumar
Published In
Kidney Int Rep
Nucleic Acids Res
Nephrology (Carlton)
Indian J Cancer
Trop Doct
Affiliations
Soon will be listed here.
Recent Articles
1.
ANCA-Associated Vasculitis with Systemic Thrombotic Microangiopathy: A Review of Literature
Shukla S, Sekar A, Naik S, Rathi M, Sharma A, Nada R, et al.
Indian J Nephrol . 2024 Apr; 34(2):155-161. PMID: 38681020
Introduction: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) rarely coexist with systemic thrombotic microangiopathy (TMA).The TMA can be in the form of either hemolytic uremic syndrome (HUS) or thrombotic thrombocytopenic purpura...
2.
WHOOP: whale optimization-based optimal placement of hub node within a WBAN
Shukla S, Sachan V, Sinha A, Pandey S, Rao G, Shah M, et al.
Sci Rep . 2024 Feb; 14(1):3422. PMID: 38341483
Biosensor nodes of a wireless body area network (WBAN) transmit physiological parameter data to a central hub node, spending a substantial portion of their energy. Therefore, it is crucial to...
3.
Prevalence of asymptomatic brain metastases in metastatic nonsquamous nonsmall cell lung cancer: Treatment implications for resource-constrained settings
Shukla S, Prasad K, Ahuja C, Muthu V, Singh N
Indian J Cancer . 2023 Dec; 61(1):29-36. PMID: 38078444
Background: Brain metastases (BM) are common in metastatic nonsmall cell lung cancer (NSCLC). However, routine neuroimaging in asymptomatic patients with metastatic NSCLC is controversial as there is no conclusive evidence...
4.
Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
Naik S, Pal D, Shukla S, Kumar V, Kumar A, Jha V, et al.
Kidney Int Rep . 2023 Aug; 8(8):1660-1664. PMID: 37547518
No abstract available.
5.
Rituximab in Primary Membranous Nephropathy With Severe CKD
Naik S, Shukla S, Kumar V, Sain T, Sekar A, Pal D, et al.
Kidney Int Rep . 2023 Jun; 8(6):1270-1271. PMID: 37284669
No abstract available.
6.
Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD
Naik S, Shukla S, Av N, Kumar V, Sekar A, Nada R, et al.
Kidney Int Rep . 2023 Apr; 8(4):942-943. PMID: 37069971
No abstract available.
7.
Anti-neutrophil cytoplasmic antibody-associated vasculitis with haemolytic uraemic syndrome
Shukla S, Sekar A, Naik S, Rathi M, Sharma A, Nada R, et al.
Intern Med J . 2022 Aug; 52(8):1450-1451. PMID: 35973952
No abstract available.
8.
Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis
Sharma S, Kalra S, Shukla S, Sharma P
Nephrology (Carlton) . 2022 May; 27(9):758-762. PMID: 35619554
Background: Children with frequently relapsing (FR) or steroid dependent (SD) nephrotic syndrome (NS) often develop side effects of corticosteroids. Various steroid-sparing agents are in practice, but only a few studies...
9.
Acute kidney injury post coronary angioplasty
Naik S, Shukla S, Sethi J, Sekar A
BMJ Case Rep . 2022 Mar; 15(3). PMID: 35236711
No abstract available.
10.
Pyrexia of unknown origin in HIV-negative adults from Himachal Pradesh (India): will you suspect disseminated histoplasmosis?
Arora N, Shukla S, Vijaykumar D, Suri V, Kumar R, Pannu A
Trop Doct . 2020 Feb; 50(3):275-277. PMID: 32098613
Histoplasmosis is usually clinically suspected only in people who reside in, are migrants from or are travelling to endemic areas such as North America. Immunocompetent patients with a low level...